Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-13961
Kaufmann, P A (2007). The future of positron emission tomography/computed tomography imaging of the heart. Heart and Metabolism, (34):1-4.
Metabolic cardiac imaging with [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) has been established as the diagnostic and prognostic gold standard. This is usually combined with a perfusion scan, as the classical diagnostic finding is the so-called flow–metabolism mismatch (low flow, preserved FDG uptake). Hybrid PET/computed tomography (CT) and single photon emission computed tomography (SPECT)/CT scanners add a new dimension to non invasive diagnostic procedures, as they allow simultaneous assessment of function (metabolism or perfusion) and coronary anatomy. Hybrid imaging can integrate metabolic FDG information with CT-visualized
anatomy, thus providing a new approach for diagnosing dysfunctional but viable myocardium by directly visualizing information on viability in segments subtended by severely stenosed/occluded coronary vessels.
|Item Type:||Journal Article, not refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Nuclear Medicine|
04 Faculty of Medicine > Center for Integrative Human Physiology
|DDC:||570 Life sciences; biology|
610 Medicine & health
|Deposited On:||22 Mar 2009 17:22|
|Last Modified:||23 Nov 2012 14:27|
|Publisher:||Lippincott Wiliams & Wilkins|
|Related URLs:||http://www.heartandmetabolism.org/ (Publisher)|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page